Specifically, treatment with a pan-Hsp90 inhibitor was shown to improve glucose homeostasis and insulin sensitivity in db/db and diet-induced obese (DIO) mouse models of diabetes, respectively [5]. The gene discussed is HSP90AA1; the disease is diabetes mellitus.